Robert Geckeler

Mr. Geckeler has over 25 years of pharmaceutical industry experience spanning a wide range of product formats and therapeutic areas, including pain management, CNS disorders, cardiovascular disease, and oncology. He has managed and led global therapeutic development programs ranging from first-in-man and proof-of-concept studies through pivotal registration trials and product registration and launch efforts. As an independent consultant, Robert has supported a number of early- and mid-stage clinical programs for startup pharmaceutical and biotech companies, providing broad support for their development activities. Most recently, he served on the board of Cerion NRx and was the EVP of Operations at Telephus Biosciences. Prior to that, he was VP of Development at Xenome Ltd., and has held project leadership and management positions at Elan, Arena, and Avera.

Across those roles, his responsibilities have included oversight of all aspects of the clinical-stage development effort, business development, the assessment of market opportunities, and life cycle management for marketed products. Mr. Geckeler also has cutting-edge experience in the Digital Health sector, gained while leading account management at OneHealth, an online and mobile platform that used social networking and programs to facilitate patient self-management of chronic conditions (now part of Virgin Pulse).

Robert has a B.A. in Biology from Washington University in St. Louis and an MBA from San Diego State University. Prior to joining the pharmaceutical industry, he worked in the viral immunobiology unit at the Research Institute of Scripps Clinic in La Jolla.